Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
1 "Sensory thresholds"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Complications
Patterns of Nerve Conduction Abnormalities in Patients with Type 2 Diabetes Mellitus According to the Clinical Phenotype Determined by the Current Perception Threshold
Joong Hyun Park, Jong Chul Won
Diabetes Metab J. 2018;42(6):519-528.   Published online October 24, 2018
DOI: https://doi.org/10.4093/dmj.2018.0068
  • 5,515 View
  • 77 Download
  • 14 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   
Background

Clinical manifestations of diabetic peripheral neuropathy (DPN) vary along the course of nerve damage. Nerve conduction studies (NCS) have been suggested as a way to confirm diagnoses of DPN, but the results have limited utility for evaluating clinical phenotypes. The current perception threshold (CPT) is a complementary method for diagnosing DPN and assessing DPN symptoms. We compared NCS variables according to clinical phenotypes determined by CPT measurements.

Methods

We retrospectively enrolled patients with type 2 diabetes mellitus who underwent both NCS and CPT tests using a neurometer. CPT grades were used to determine the clinical phenotypes of DPN: normoesthesia (0 to 1.66), hyperesthesia (1.67 to 6.62), and hypoesthesia/anesthesia (6.63 to 12.0). The Michigan Neuropathy Screening Instrument (MNSI) was used to determine a subjective symptom score. DPN was diagnosed based on both patient symptoms (MNSI score ≥3) and abnormal NCS results.

Results

A total of 202 patients (117 men and 85 women) were included in the final analysis. The average age was 62.6 years, and 71 patients (35.1%) were diagnosed with DPN. The CPT variables correlated with MNSI scores and NCS variables in patients with diabetes. Linear regression analyses indicated that hypoesthesia was associated with significantly lower summed velocities and sural amplitudes and velocities, and higher summed latencies, than normoesthesia. Sural amplitude was significantly lower in patients with hyperesthesia than in patients with normoesthesia.

Conclusion

NCS variables differed among patients with diabetes according to clinical phenotypes based on CPT and decreased sural nerve velocities was associated with hyperesthesia.

Citations

Citations to this article as recorded by  
  • Evoked sensations with transcutaneous electrical stimulation with different frequencies, waveforms, and electrode configurations
    Eukene Imatz‐Ojanguren, Thierry Keller
    Artificial Organs.2023; 47(1): 117.     CrossRef
  • Cognitive function in individuals with and without painful and painless diabetic polyneuropathy—A cross‐sectional study in type 1 diabetes
    Suganthiya S. Croosu, Mimoza Gjela, Johan Røikjer, Tine M. Hansen, Carsten D. Mørch, Jens B. Frøkjær, Niels Ejskjaer
    Endocrinology, Diabetes & Metabolism.2023;[Epub]     CrossRef
  • Adherence and the Diabetic Foot: High Tech Meets High Touch?
    Hadia Srass, J. Karim Ead, David G. Armstrong
    Sensors.2023; 23(15): 6898.     CrossRef
  • Glomerular filtration Rate, urine Albumin/ creatinine ratio and current perception threshold in patients with diabetic kidney disease
    Cheng-Xian Pi, Teng-Juan Gui, Qi-Da He, Fang Yin, Ren-Jiao Cai, Yue Wang, Qiu-Xia Xue, Xin-Kui Tian, Tao Wang, Xing–Wei Zhe
    Diabetes Research and Clinical Practice.2022; 189: 109934.     CrossRef
  • Efficacy and Safety of α-Lipoic Acid and Low Dose Pregabalin Combination in Painful Diabetic Neuropathy
    Ki-Tae Park, Jin-Kwang Lee, Se Jin Park
    Journal of Korean Foot and Ankle Society.2022; 26(4): 177.     CrossRef
  • Association between Sleep Quality and Painless Diabetic Peripheral Neuropathy Assessed by Current Perception Threshold in Type 2 Diabetes Mellitus
    Dughyun Choi, Bo-Yeon Kim, Chan-Hee Jung, Chul-Hee Kim, Ji-Oh Mok
    Diabetes & Metabolism Journal.2021; 45(3): 358.     CrossRef
  • The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus
    Manal Mohammed Hashem, Ahmed Esmael, Abdelfattah Kasem Nassar, Mohammed El-Sherif
    Scientific Reports.2021;[Epub]     CrossRef
  • New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine
    Heng Yang, Gordon Sloan, Yingchun Ye, Shuo Wang, Bihan Duan, Solomon Tesfaye, Ling Gao
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial
    Jong Chul Won, Hyuk-Sang Kwon, Seong-Su Moon, Sung Wan Chun, Chong Hwa Kim, Ie Byung Park, In Joo Kim, Jihyun Lee, Bong Yun Cha, Tae Sun Park
    Diabetes & Metabolism Journal.2020; 44(4): 542.     CrossRef
  • Supplementation with Korean Red Ginseng Improves Current Perception Threshold in Korean Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
    Kahui Park, YuSik Kim, Junghye Kim, Shinae Kang, Jong Suk Park, Chul Woo Ahn, Ji Sun Nam
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention
    Dinesh Selvarajah, Debasish Kar, Kamlesh Khunti, Melanie J Davies, Adrian R Scott, Jeremy Walker, Solomon Tesfaye
    The Lancet Diabetes & Endocrinology.2019; 7(12): 938.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal